Trial intelligence / Profile preview

Flurbiprofen Axetil and Nalbuphine for Postoperative Pain after Oculoplastic Surgery

NCT03422887Completed

Sponsor
Sun Yat-sen University
Start
Jan 2018
Primary completion
Aug 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, triple-blind trial of flurbiprofen axetil and nalbuphine in postoperative pain, sponsored by Sun Yat-sen University. Primary endpoint: Pain 24 hours after recovery. Started Jan 2018; status: completed.

02

Drugs

flurbiprofen axetilnalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03422887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03422887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call